IPOPLUS

162.48

-0.16 -0.10%

18 Jun 2026

NSE Listed · Pharmaceuticals

Ind-Swift Laboratories Ltd. (INDSWFTLAB)

Volume: 37,697Avg Vol 1W: 1,05,954Avg Vol 1M: 7,63,58952W Range:87.15173.25
₹162.48 0.10%
Market Cap₹1,417 Cr
Current Price₹162.48
Previous Close₹162.64
High / Low (52w)₹173.25 / ₹87.15
Volume37,697
Avg Vol (1W)1,05,954
Avg Vol (1M)7,63,589
Stock P/E2.3
Book Value₹159.38
Dividend Yield0%
ROE3.57%
ROA2.47%
Revenue (TTM)
Revenue Growth-67.13%
Profit Margin6.61%
Total Debt₹8 Cr
Shares Outstanding9 Cr
Face Value₹10
EPS (TTM)₹1.81
P/B1.01
Debt / Equity0.01
50 DMA₹146.79
200 DMA₹137.51
Day change-0.10%
Price Chart
162.48 53.98% · 1Y
164881.3Cr
2025-10-20
2026-06-16

20-day avg volume: 5.1L shares

Pros
  • Company is almost debt-free.
Cons
  • Revenue fell 64% YoY.
Quarterly Results
MetricMar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024Jun 2024Mar 2024Dec 2023Sept 2023Jun 2023Mar 2023Dec 2022Sept 2022Jun 2022Mar 2022Dec 2021Sept 2021Jun 2021Mar 2021Dec 2020Sept 2020Jun 2020Mar 2020
Revenue₹170 Cr₹151 Cr₹153 Cr₹153 Cr₹138 Cr₹129 Cr₹12 Cr₹33 Cr₹529 Cr₹288 Cr₹290 Cr₹310 Cr₹304 Cr₹313 Cr₹310 Cr₹280 Cr₹307 Cr₹247 Cr₹236 Cr₹250 Cr₹227 Cr₹226 Cr₹228 Cr₹210 Cr₹192 Cr
EBITDA₹15 Cr₹23 Cr₹12 Cr₹12 Cr₹-12 Cr₹4 Cr₹1 Cr₹1 Cr₹143 Cr₹45 Cr₹60 Cr₹52 Cr₹65 Cr₹47 Cr₹50 Cr₹44 Cr₹-24 Cr₹40 Cr₹49 Cr₹43 Cr₹16 Cr₹37 Cr₹35 Cr₹30 Cr₹25 Cr
Net Profit₹15 Cr₹10 Cr₹8 Cr₹9 Cr₹222 Cr₹-5 Cr₹0 Cr₹1 Cr₹494 Cr₹19 Cr₹32 Cr₹17 Cr₹-25 Cr₹28 Cr₹25 Cr₹20 Cr₹-61 Cr₹16 Cr₹24 Cr₹19 Cr₹-29 Cr₹12 Cr₹10 Cr₹5 Cr₹3 Cr
EPS1.761.130.961.1730.08-0.820.070.1683.553.295.362.92-4.254.654.293.36-10.42.714.143.18-4.941.951.690.770.6
Profit & Loss (Annual)
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Revenue₹643 Cr₹1,797 Cr₹1,241 Cr₹1,082 Cr₹914 Cr₹813 Cr
EBITDA₹38 Cr₹311 Cr₹205 Cr₹108 Cr₹118 Cr₹88 Cr
Net Profit₹250 Cr₹539 Cr₹48 Cr₹-2 Cr₹-3 Cr₹-21 Cr
EPS35.2191.18-4.28-0.36-0.53-4.28
Balance Sheet
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Total Assets₹1,438 Cr₹1,460 Cr₹1,824 Cr₹1,801 Cr₹1,818 Cr₹1,870 Cr
Total Liabilities₹265 Cr₹648 Cr₹1,142 Cr₹1,200 Cr₹1,215 Cr₹1,229 Cr
Equity₹1,173 Cr₹812 Cr₹682 Cr₹601 Cr₹603 Cr₹641 Cr
Total Debt₹8 Cr₹176 Cr₹744 Cr₹51 Cr₹82 Cr₹110 Cr
Cash Flow
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Operating₹-25 Cr₹-187 Cr₹195 Cr₹150 Cr₹135 Cr₹125 Cr
Investing₹-110 Cr₹-27 Cr₹-13 Cr₹5 Cr₹-10 Cr₹-9 Cr
Financing₹69 Cr₹657 Cr₹-186 Cr₹-141 Cr₹-124 Cr₹-133 Cr
Free Cash Flow₹-25 Cr₹-187 Cr₹195 Cr₹150 Cr₹135 Cr₹125 Cr
Shareholding
Promoter 42.99% Institutions 13.88% Public 43.12%

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search